COMPASS BIOINFORMATICS INC.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
InheriNext® is an AI-powered NGS analysis platform by Compass Bioinformatics, FDA Class I SaMD certified. Its modular design automates and streamlines the entire workflow—from sequencing data to clinical reporting—enabling fast, accurate, and standardized
Founded Year
2015
Unified Business No.
24727426
Status
Active
Number of Employees
0
Total Paid-in
Capital
356,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Compass Bioinformatics is committed to becoming a global leader in Software as a Medical Device (SaMD) for multi-omics. We are a team of clinicians, AI data scientists, bioinformatics experts, and system developers across USA, Japan, and Taiwan.
